2,882
Views
20
CrossRef citations to date
0
Altmetric
Article

Co-exposure to silver nanoparticles and cadmium induce metabolic adaptation in HepG2 cells

, , , , &
Pages 781-795 | Received 21 Nov 2017, Accepted 11 Jun 2018, Published online: 11 Jul 2018

References

  • Arbuckle, T. E., C. L. Liang, A.-S. Morisset, M. Fisher, H. Weiler, C. M. Cirtiu, M. Legrand, K. Davis, A. S. Ettinger, and W. D. Fraser. 2016. “Maternal and Fetal Exposure to Cadmium, Lead, Manganese and Mercury: The MIREC Study.” Chemosphere 163: 270–282. doi:10.1016/j.chemosphere.2016.08.023.
  • Baird, T., and R. Wek. 2012. “Eukaryotic Initiation Factor 2 Phosphorylation and Translational Control in Metabolism.” Advances in Nutrition 3 (3): 307–321. doi:10.3945/an.112.002113.
  • Capaldo, A., F. Gay, R. Scudiero, F. Trinchella, I. Caputo, M. Lepretti, A. Marabotti, C. Esposito, and V. Laforgia. 2016. “Histological Changes, Apoptosis and Metallothionein Levels in Triturus Carnifex (Amphibia, Urodela) Exposed to Environmental Cadmium Concentrations.” Aquatic Toxicology 173: 63–73. doi:10.1016/j.aquatox.2016.01.009.
  • Carracedo, A., L. C. Cantley, and P. P. Pandolfi. 2013. “Cancer Metabolism: Fatty Acid Oxidation in the Limelight.” Nature Reviews Cancer 13 (4): 227–232. doi:10.1038/nrc3483.
  • Chapple, S. J., R. C. M. Siow, and G. E. Mann. 2012. “Crosstalk between Nrf2 and the Proteasome: Therapeutic Potential of Nrf2 Inducers in Vascular Disease and Aging.” International Journal of Biochemistry and Cell Biology 44 (8): 1315–1320. doi:10.1016/j.biocel.2012.04.021.
  • Cleveland, D., S. E. Long, P. L. Pennington, E. Cooper, M. H. Fulton, G. I. Scott, T. Brewer, J. Davis, E. J. Petersen, and L. Wood. 2012. “Pilot Estuarine Mesocosm Study on the Environmental Fate of Silver Nanomaterials Leached from Consumer Products.” Science of the Total Environment 421–422: 267–272. doi:10.1016/j.scitotenv.2012.01.025.
  • Cuypers, A., Plusquin, M., Remans, T. Jozefczak, M. Keunen, E. Gielen, H. Opdenakker, K. Nair, A. R. Munters, E. Artois. T. J., et al.. 2010. “Cadmium Stress: An Oxidative Challenge.” Biometals 23 (5): 927–940. doi:10.1007/s10534-010-9329-x.
  • de Vries, H. E., M. Witte, D. Hondius, A. J. Rozemuller, B. Drukarch, J. Hoozemans, and J. van Horssen. 2008. “Nrf2-Induced Antioxidant Protection: A Promising Target to Counteract ROS-Mediated Damage in Neurodegenerative Disease?.” Free Radical Biology and Medicine 45 (10): 1375–1383. doi:10.1016/j.freeradbiomed.2008.09.001.
  • Della Torre, C., T. Balbi, G. Grassi, G. Frenzilli, M. Bernardeschi, A. Smerilli, P. Guidi, L. Canesi, M. Nigro, F. Monaci, et al. 2015. “Titanium Dioxide Nanoparticles Modulate the Toxicological Response to Cadmium in the Gills of Mytilus Galloprovincialis.” Journal of Hazardous Materials 297: 92–100. doi:10.1016/j.jhazmat.2015.04.072.
  • Deville, S., B. Baré, J. Piella, K. Tirez, P. Hoet, M. P. Monopoli, K. A. Dawson, V. F. Puntes, and I. Nelissen. 2016. “Interaction of Gold Nanoparticles and Nickel(II) Sulfate Affects Dendritic Cell Maturation.” Nanotoxicology 10 (10): 1395–1403. doi:10.1080/17435390.2016.1221476.
  • Donnelly, N., A. M. Gorman, S. Gupta, and A. Samali. 2013. “The eIF2α kinases: Their Structures and functions.” Cellular and Molecular Life Sciences 70 (19): 3493–3511. doi:10.1007/s00018-012-1252-6.
  • Ferreira, J. L., M. N. Lonné, T. A. França, N. R. Maximilla, T. H. Lugokenski, P. G. Costa, G. Fillmann, F. A. Antunes Soares, F. R. de la Torre, J. M. Monserrat. 2014. “Co-Exposure of the Organic Nanomaterial Fullerene C60 with Benzo[a]Pyrene in Danio rerio (Zebrafish) Hepatocytes: Evidence of Toxicological Interactions.” Aquatic Toxicology 147: 76–83. doi:10.1016/j.aquatox.2013.12.007.
  • Franceschini, A., D. Szklarczyk, S. Frankild, M. Kuhn, M. Simonovic, A. Roth, J. Lin, P. Minguez, P. Bork, C. Von Mering, and L. J. Jensen. 2013. “STRING v9.1: Protein-Protein Interaction Networks, with Increased Coverage and Integration.” Nucleic Acids Research 41 (D1): D808–D815. doi:10.1093/nar/gks1094.
  • Furman, O., S. Usenko, and B. L. T. Lau. 2013. “Relative Importance of the Humic and Fulvic Fractions of Natural Organic Matter in the Aggregation and Deposition of Silver Nanoparticles.” Environmental Science & Technology 47 (3): 1349–1356. doi:10.1021/es303275g.
  • Glickman, M. H., and A. Ciechanover. 2002. “The Ubiquitin-Proteasome Proteolytic Pathway: Destruction for the Sake of Construction.” Physiological Reviews 82 (2): 373–428. doi:10.1152/physrev.00027.2001.
  • Gliga, A. R., S. Skoglund, I. O. Wallinder, B. Fadeel, and H. L. Karlsson. 2014. “Size-Dependent Cytotoxicity of Silver Nanoparticles in Human Lung Cells: The Role of Cellular Uptake, Agglomeration and Ag Release.” Particle and Fibre Toxicology 11 (1): 11. doi:10.1186/1743-8977-11-11.
  • Goldoni, M., and C. Johansson. 2007. “A Mathematical Approach to Study Combined Effects of Toxicants in Vitro: Evaluation of the Bliss Independence Criterion and the Loewe Additivity Model.” Toxicology in Vitro 21 (5): 759–769. doi:10.1016/j.tiv.2007.03.003.
  • Govindasamy, R., and A. A. Rahuman. 2012. “Histopathological Studies and Oxidative Stress of Synthesized Silver Nanoparticles in Mozambique Tilapia (Oreochromis mossambicus).” Journal of Environmental Sciences 24 (6): 1091–1098.
  • Guo, M., X. Xu, X. Yan, S. Wang, S. Gao, and S. Zhu. 2013. “In Vivo Biodistribution and Synergistic Toxicity of Silica Nanoparticles and Cadmium Chloride in Mice.” Journal of Hazardous Materials 260: 780–788. doi:10.1016/j.jhazmat.2013.06.040.
  • Han, X., R. Gelein, N. Corson, P. Wade-Mercer, J. Jiang, P. Biswas, J. N. Finkelstein, A. Elder, and G. Oberdörster. 2011. “Validation of an LDH Assay for Assessing Nanoparticle Toxicity.” Toxicology 287 (1–3): 99–104. doi:10.1016/j.tox.2011.06.011.
  • Holmström, K. M., and T. Finkel. 2014. “Cellular Mechanisms and Physiological Consequences of Redox-Dependent Signalling.” Nature Reviews Molecular Cell Biology 15 (6): 411–421. doi:10.1038/nrm3801.
  • Houten, S. M., and R. J. A. Wanders. 2010. “A General Introduction to the Biochemistry of Mitochondrial Fatty Acid β -Oxidation.” Journal of Inherited Metabolic Disease 33 (5): 469–477.
  • Itoh, K., N. Wakabayashi, Y. Katoh, T. Ishii, T. O'Connor, and M. Yamamoto. 2003. “Keap1 Regulates Both Cytoplasmic-Nuclear Shuttling and Degradation of Nrf2 in Response to Electrophiles.” Genes to Cells 8 (4): 379–391.
  • Iyer, V. V., H. Yang, M. G. Ierapetritou, and C. M. Roth. 2010. “Effects of Glucose and Insulin on HepG2-C3A Cell Metabolism.” Biotechnology and Bioengineering 107 (2): 347–356. doi:10.1002/bit.22799.
  • Kamalian, L., A. E. Chadwick, M. Bayliss, N. S. French, M. Monshouwer, J. Snoeys, and B. K. Park. 2015. “The Utility of HepG2 Cells to Identify Direct Mitochondrial Dysfunction in the Absence of Cell Death.” Toxicology in Vitro 29 (4): 732–740. doi:10.1016/j.tiv.2015.02.011.
  • Lee, S., E. Hur, G. I. G. Ryoo, K. A. Jung, J. Kwak and M. K. Kwak. 2012. “Involvement of the Nrf2-Proteasome Pathway in the Endoplasmic Reticulum Stress Response in Pancreatic??-Cells.” Toxicology and Applied Pharmacology 264 (3): 431–438. doi:10.1016/j.taap.2012.08.021.
  • Liberti, M. V., and J. W. Locasale. 2016. “The Warburg Effect: How Does It Benefit Cancer Cells?.” Trends in Biochemical Sciences 41 (3): 211–218. doi:10.1016/j.tibs.2015.12.001.
  • Maurer-Jones, M. A., I. L. Gunsolus, C. J. Murphy, and C. L. Haynes. 2013. “Toxicity of Engineered Nanoparticles in the Environment.” Analytical Chemistry 85 (6): 3036–3049. doi:10.1021/ac303636s.
  • Miranda, R. R., A. G. Bezerra, C. A. O. Ribeiro, M. A. F. Randi, C. L. Voigt, L. Skytte, K. L. Rasmussen, F. Kjeldsen, and F. F. Neto. 2017. “Toxicological Interactions of Silver Nanoparticles and Non-Essential Metals in Human Hepatocarcinoma Cell Line.” Toxicology in Vitro 40: 134–143. doi:10.1016/j.tiv.2017.01.003.
  • Mitsuishi, Y., K. Taguchi, Y. Kawatani, T. Shibata, T. Nukiwa, H. Aburatani, M. Yamamoto, and H. Motohashi. 2012. “Nrf2 Redirects Glucose and Glutamine into Anabolic Pathways in Metabolic Reprogramming.” Cancer Cell 22 (1): 66–79.
  • Moreau, A., M. J. Vilarem, P. Maurel, and J. M. Pascussi. 2008. “Xenoreceptors CAR and PXR Activation and Consequences on Lipid Metabolism, Glucose Homeostasis, and Inflammatory Response.” Molecular Pharmaceutics 5 (1): 35–41. doi:10.1021/mp700103m.
  • Mukherjee, R., L. Jow, G. E. Croston, and J. R. Paterniti. 1997. “Identification, Characterization, and Tissue Distribution of Human Peroxisome Proliferator-Activated Receptor (PPAR) Isoforms PPARgamma2 versus PPARgamma1 and Activation with Retinoid X Receptor Agonists and Antagonists.” The Journal of Biological Chemistry 272 (12): 8071–8076.
  • Navarro, E., F. Piccapietra, B. Wagner, F. Marconi, R. Kaegi, N. Odzak, L. Sigg, and R. Behra. 2008. “Toxicity of Silver Nanoparticles to Chlamydomonas reinhardtii.” Environmental Science & Technology 42 (23): 8959–8964. doi:10.1021/es801785m.
  • Pineda Torra, I., T. Claudel, C. Duval, V. Kosykh, J.-C. Fruchart, and B. Staels. 2003. “Bile Acids Induce the Expression of the Human Peroxisome Proliferator-Activated Receptor α Gene via Activation of the Farnesoid X Receptor.” Molecular Endocrinology 17 (2): 259–272. doi:10.1210/me.2002-0120.
  • Rinaldi, C., T. Schmidt, A. J. Situ, J. O. Johnson, P. R. Lee, K.-L. Chen, L. C. Bott, R. Fadó, G. H. Harmison, S. Parodi, et al. 2015. “Mutation in CPT1C Associated with Pure Autosomal Dominant Spastic Paraplegia.” JAMA Neurology 72 (5): 561–570. doi:10.1001/jamaneurol.2014.4769.
  • Rodríguez-Enríquez, S., O. Juárez, J. S. Rodríguez-Zavala, and R. Moreno-Sánchez. 2001. “Multisite Control of the Crabtree Effect in Ascites Hepatoma Cells.” European Journal of Biochemistry 268 (8): 2512–2519.
  • Schwämmle, V., I. R. León, and O. N. Jensen. 2013. “Assessment and Improvement of Statistical Tools for Comparative Proteomics Analysis of Sparse Data Sets with Few Experimental Replicates.” Journal of Proteome Research 12 (9): 3874–3883. doi:10.1021/pr400045u.
  • Taverner, T., Y. V. Karpievitch, A. D. Polpitiya, J. N. Brown, A. R. Dabney, G. A. Anderson, and R. D. Smith. 2012. “DanteR: An Extensible R-Based Tool for Quantitative Analysis of -Omics Data.” Bioinformatics (Oxford, England) 28 (18): 2404–2406.
  • Vance, M. E., T. Kuiken, E. P. Vejerano, S. P. McGinnis, M. F. Hochella, D. Rejeski, and M. S. Hull. 2015. “Nanotechnology in the Real World: Redeveloping the Nanomaterial Consumer Products Inventory.” Beilstein Journal of Nanotechnology 6: 1769–1780. doi:10.3762/bjnano.6.181.
  • Vriend, J., and R. J. Reiter. 2015. “The Keap1-Nrf2-Antioxidant Response Element Pathway: A Review of Its Regulation by Melatonin and the Proteasome.” Molecular and Cellular Endocrinology 401: 213–220. doi:10.1016/j.mce.2014.12.013.
  • Wildt, B. E., A. Celedon, E. I. Maurer, B. J. Casey, A. M. Nagy, S. M. Hussain, and P. L. Goering. 2016. “Intracellular Accumulation and Dissolution of Silver Nanoparticles in L-929 Fibroblast Cells Using Live Cell Time-Lapse Microscopy.” Nanotoxicology 10 (6): 710. doi:10.3109/17435390.2015.1113321.
  • Zhang, C., Z. Hu, and B. Deng. 2016. “Silver Nanoparticles in Aquatic Environments: Physiochemical Behavior and Antimicrobial Mechanisms.” Water Research 88: 403–427. doi:10.1016/j.watres.2015.10.025.